Duesseldorf Officially Welcomes EuroMedtech™
International Medtech Partnering Conference
Carlsbad, USA, Zurich, Switzerland, and Duesseldorf,
Germany, May 5, 2009: Leaders from the city of
Duesseldorf, the German Federal State of North Rhine-Westphalia
and luminaries from both the German and international
medical technology industry officially welcomed EuroMedtech™
2009. To be held at the Maritim Hotel in Duesseldorf,
Germany June 3–4, 2009, EuroMedtech 2009 will bring
together decision makers from all sectors of Europe’s
fast growing and highly innovative medical technology
sector.
“Duesseldorf recognizes that collaboration is essential
for the continued growth of our medtech industry. We believe
that the formation of partnerships between emerging innovators
and large multidisciplinary health care and medical research
firms will support vibrant growth of our industry,” said
Wilfried Kruse, Commissioner for Organization, Human Resources,
IT, Economic Development and Public Health of the City
of Duesseldorf.
Duesseldorf is a hothouse for developing innovative
enterprises, many of which are cultivated within world-class
research institutions such as the Heinrich Heine University.
The region today boasts over 65 life science firms, including
medtech market leaders Medtronic, 3M Medica and Qiagen.
Mr. Kruse added, “The EuroMedtech conference provides
a unique opportunity for the global medtech community
to identify potential collaborations critical for tomorrow’s
top line growth.”
BIO.NRW Cluster Biotechnology North Rhine-Westphalia
develops networks among companies and academic institutions,
and is one of the regional hosts of EuroMedtech 2009.
Dr. Bernward Garthoff, Clustermanager for BIO.NRW, stated,
“We are very happy to have EuroMedtech in NRW. This conference
heightens NRW’s profile towards an international audience.”
Carola Schropp, President of EBD Group, added, “We are
honored to hold the first annual EuroMedtech event in
the dynamic city of Duesseldorf. As a home to some of
the most exciting medtech companies, EBD Group looks forward
to helping the region assert its leadership role in the
global medtech industry. EuroMedtech brings together decision
makers from innovation-intensive sectors of the medtech
industry in a setting conducive to exploring and developing
new strategic partnerships.”
About EBD Group
EBD Group is the leading partnering firm for the global
life science industry. Since 1993, biotech, pharma and
medical device companies have leveraged EBD Group’s partnering
conferences, technology and services to identify business
opportunities and develop strategic relationships essential
to their success. EBD Group’s conferences are run with
the support of leading corporations and international
trade associations and include:
- BIO-Europe and BIO-Europe Spring®, the
world's largest stand-alone life science partnering
conferences, supported by the Biotechnology Industry
Organization (BIO)
- BioPharm America™, EBD Group’s North American partnering
event
- EuroMedtech™, EBD Group’s new partnering event for
the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized
with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated
biotech/pharma partnering conference in China
EBD Group’s sophisticated web-based partnering service,
partneringONE™, is used as the partnering engine at numerous
third-party events around the world. Outside of the conference
format, EBD Group’s consultants provide hands-on assistance
for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
